Suke Lan

491 total citations
23 papers, 394 citations indexed

About

Suke Lan is a scholar working on Molecular Biology, Materials Chemistry and Oncology. According to data from OpenAlex, Suke Lan has authored 23 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Materials Chemistry and 6 papers in Oncology. Recurrent topics in Suke Lan's work include Protein Degradation and Inhibitors (6 papers), Metal-Organic Frameworks: Synthesis and Applications (5 papers) and Advanced Nanomaterials in Catalysis (4 papers). Suke Lan is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Metal-Organic Frameworks: Synthesis and Applications (5 papers) and Advanced Nanomaterials in Catalysis (4 papers). Suke Lan collaborates with scholars based in China. Suke Lan's co-authors include Sheng‐Tao Yang, Qun Li, Xian Wu, Chunlan Pu, Guoyi Yan, Rui Li, Xin-Xin Zhong, Jie Yang, Xueyan Hou and Xin Guan and has published in prestigious journals such as Journal of Hazardous Materials, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Suke Lan

22 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suke Lan China 13 150 136 80 77 75 23 394
Zhengyan Wang China 13 158 1.1× 113 0.8× 60 0.8× 132 1.7× 24 0.3× 32 492
Liting Yu China 10 185 1.2× 84 0.6× 32 0.4× 109 1.4× 86 1.1× 31 523
Wenqian Li China 11 249 1.7× 74 0.5× 120 1.5× 108 1.4× 54 0.7× 18 547
Yamixa Delgado Puerto Rico 13 278 1.9× 102 0.8× 105 1.3× 46 0.6× 137 1.8× 31 621
Nana Yu China 13 159 1.1× 260 1.9× 37 0.5× 40 0.5× 108 1.4× 21 641
Karina Alexandre Barros Nogueira Brazil 8 106 0.7× 104 0.8× 55 0.7× 22 0.3× 82 1.1× 10 365
Inês Matias Portugal 8 88 0.6× 56 0.4× 40 0.5× 35 0.5× 38 0.5× 20 415
Benan Kılbaş Türkiye 13 88 0.6× 204 1.5× 134 1.7× 100 1.3× 85 1.1× 26 650
Deyu Wu China 15 196 1.3× 113 0.8× 36 0.5× 27 0.4× 116 1.5× 31 603
Zhengzhong Kang China 13 235 1.6× 291 2.1× 33 0.4× 228 3.0× 251 3.3× 32 714

Countries citing papers authored by Suke Lan

Since Specialization
Citations

This map shows the geographic impact of Suke Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suke Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suke Lan more than expected).

Fields of papers citing papers by Suke Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suke Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suke Lan. The network helps show where Suke Lan may publish in the future.

Co-authorship network of co-authors of Suke Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Suke Lan. A scholar is included among the top collaborators of Suke Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suke Lan. Suke Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pu, Chunlan, et al.. (2024). Enhancing therapeutic efficacy in homologous recombination-proficient pancreatic cancer via the combination of PARP1-PROTAC and a BRD4 inhibitor. Bioorganic & Medicinal Chemistry. 115. 117970–117970. 4 indexed citations
2.
Lan, Suke, Chun Zhang, Yue Yuan, et al.. (2024). Fluorescent metal–organic framework Zn-TCPP for sentinel lymph node imaging in vivo. New Journal of Chemistry. 49(2). 371–375.
3.
4.
Pu, Chunlan, Yu Tong, Yuanyuan Liu, et al.. (2022). Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer. European Journal of Medicinal Chemistry. 236. 114321–114321. 34 indexed citations
5.
Pu, Chunlan, Shirui Wang, Dan Luo, et al.. (2022). Synthesis and biological evaluation of a tumor-selective degrader of PARP1. Bioorganic & Medicinal Chemistry. 69. 116908–116908. 17 indexed citations
6.
7.
Lan, Suke, Jiahao Zhang, Xin Li, et al.. (2022). Low Toxicity of Metal-Organic Framework MOF-74(Co) Nano-Particles In Vitro and In Vivo. Nanomaterials. 12(19). 3398–3398. 24 indexed citations
8.
Yan, Guoyi, Xin-Xin Zhong, Chunlan Pu, et al.. (2021). Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design. Journal of Medicinal Chemistry. 64(3). 1558–1569. 9 indexed citations
9.
Ma, Xinyu, Guoyi Yan, Xin-Xin Zhong, et al.. (2021). Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold. European Journal of Medicinal Chemistry. 219. 113432–113432. 12 indexed citations
10.
Shi, Mengyao, Suke Lan, Chun Zhang, et al.. (2021). Biocompatible zinc gallogermanate persistent luminescent nanoparticles for fast tumor drainage lymph node imaging in vivo. Colloids and Surfaces B Biointerfaces. 205. 111887–111887. 6 indexed citations
11.
Yan, Guoyi, Xin-Xin Zhong, Yue Lin, et al.. (2021). Discovery of a PROTAC targeting ALK with in vivo activity. European Journal of Medicinal Chemistry. 212. 113150–113150. 41 indexed citations
12.
Ma, Qiang, Qiangqiang Zhang, Suke Lan, et al.. (2021). Carbonization reduces the toxicity of metal-organic framework MOF-199 to white-rot fungus Phanerochaete chrysosporium. Journal of environmental chemical engineering. 9(6). 106705–106705. 18 indexed citations
13.
Yang, Shengnan, Qian Chen, Mengyao Shi, et al.. (2020). Fast Identification and Quantification of Graphene Oxide in Aqueous Environment by Raman Spectroscopy. Nanomaterials. 10(4). 770–770. 21 indexed citations
14.
Yang, Jie, Chao-Guo Cao, Dan Luo, et al.. (2020). Discovery of 4-(3,5-dimethoxy-4-(((4-methoxyphenethyl)amino)methyl)phenoxy)-N-phenylaniline as a novel c-myc inhibitor against colorectal cancer in vitro and in vivo. European Journal of Medicinal Chemistry. 198. 112336–112336. 8 indexed citations
15.
Guan, Xin, et al.. (2020). Toxicity and photosynthetic inhibition of metal-organic framework MOF-199 to pea seedlings. Journal of Hazardous Materials. 409. 124521–124521. 66 indexed citations
16.
Zhang, Qiangqiang, Rui Shi, Qun Li, et al.. (2020). Low toxicity of fluorescent carbon quantum dots to white rot fungus Phanerochaete chrysosporium. Journal of environmental chemical engineering. 9(1). 104633–104633. 25 indexed citations
17.
Bai, Yitong, Xian Wu, Mengyao Shi, et al.. (2020). Surface modification mediates the interaction between fullerene and lysozyme: protein structure and antibacterial activity. Environmental Science Nano. 8(1). 76–85. 22 indexed citations
18.
Yan, Guoyi, Chunlan Pu, Suke Lan, et al.. (2019). Discovery of 4-phenyl-2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and orally active PI3K/mTOR dual inhibitors. European Journal of Medicinal Chemistry. 178. 667–686. 13 indexed citations
19.
Hou, Xueyan, Hao Luo, Mengqi Zhang, et al.. (2018). Synthesis and biological evaluation of 3-(1,3,4-oxadiazol-2-yl)-1,8-naphthyridin-4(1H)-ones as cisplatin sensitizers. MedChemComm. 9(11). 1949–1960. 5 indexed citations
20.
Yan, Guoyi, Luo Jiang, Chunlan Pu, et al.. (2017). Pharmacophore‐based virtual screening, molecular docking, molecular dynamics simulation, and biological evaluation for the discovery of novel BRD4 inhibitors. Chemical Biology & Drug Design. 91(2). 478–490. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhengyan Wang Breakdown of academic impact, for papers by Liting Yu Breakdown of academic impact, for papers by Wenqian Li Breakdown of academic impact, for papers by Yamixa Delgado Breakdown of academic impact, for papers by Nana Yu Breakdown of academic impact, for papers by Karina Alexandre Barros Nogueira Breakdown of academic impact, for papers by Inês Matias Breakdown of academic impact, for papers by Benan Kılbaş Breakdown of academic impact, for papers by Deyu Wu Breakdown of academic impact, for papers by Zhengzhong Kang
Rankless by CCL
2026